Can Keytruda (pembrolizumab) cause itching?
Yes. Itching (pruritus) is a known possible side effect of Keytruda. Because Keytruda works by activating the immune system, some skin reactions can happen during treatment.
What kind of itching is it—mild rash vs. serious skin reactions?
In many cases, itching is associated with skin irritation or a rash. However, immune-related side effects can also include more serious skin problems. If itching comes with symptoms like a widespread rash, blistering, peeling skin, or sores in the mouth/eyes, that needs urgent medical attention.
When should you get medical help for Keytruda itching?
Seek prompt medical care if:
- The itching is severe or rapidly worsening
- You develop a new rash
- You notice blistering, skin peeling, or sores
- Itching is accompanied by breathing problems, swelling, fever, or feeling very unwell
What can doctors do if itching starts?
Clinicians typically assess the skin symptoms and severity, then decide whether to use supportive skin treatments and/or immune-suppression medicines (such as corticosteroids) depending on how serious the reaction is. If the reaction is significant, Keytruda dosing may be delayed or held while treatment is managed.
How common is itching with Keytruda?
The exact frequency varies by the source and the trial/label section being cited, but itching is included among the recognized dermatologic (skin) side effects of pembrolizumab.
Does itching mean the drug is working?
Itching alone does not reliably indicate that Keytruda is working. Some immune-related side effects can correlate with treatment activity, but itching by itself is not a dependable marker of benefit.
What else could be causing itching?
Other common causes include allergies, dry skin, eczema, fungal infections, or other medications. Still, because Keytruda can trigger immune-related skin reactions, it’s important to report new or worsening itching to the oncology team promptly.
Sources:
No sources were provided with the question.